Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates

Background: Caffeine citrate has been approved in China for the management of apnea of prematurity. This clinical trial was conducted as a condition of regulatory approval. The aim was to confirm the efficacy of caffeine citrate in the treatment of recurrent intermittent hypoxia and bradycardia in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Lizhong, Tong, Xiaomei, Chen, Chao, Gao, Xirong, Gagnatelli, Alessandra, Li, Jingyang, Santoro, Debora, Nicolardi, Sara, Fabbri, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078308/
https://www.ncbi.nlm.nih.gov/pubmed/32219085
http://dx.doi.org/10.3389/fped.2020.00076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078308/
https://www.ncbi.nlm.nih.gov/pubmed/32219085
http://dx.doi.org/10.3389/fped.2020.00076

Ejemplares similares